FRONTIER MEDICINES
Frontier Medicines’is a developer of a chemoproteomics platform intended to further accelerate the path to drug discovery. The company's platform integrates advanced computational approaches and machine learning to discover and pharmacologically target new binding pockets on proteins, making them accessible to small-molecule drug discovery and development, enabling patients to consume breakthrough medicines that redefine the course of debilitating diseases.
FRONTIER MEDICINES
Industry:
Artificial Intelligence Biotechnology Pharmaceutical
Founded:
2018-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.frontiermeds.com
Total Employee:
11+
Status:
Active
Contact:
650 457 1005
Email Addresses:
[email protected]
Total Funding:
155.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Domain Not Resolving Microsoft Exchange Online Amazon
Similar Organizations
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Arctoris
Arctoris is a tech-enabled platform company in biotechnology, combining robotics & data science to accelerate drug discovery.
BenchSci
BenchSci uses machine learning and artificial intelligence to accelerate biomedical discoveries.
Cyteir Therapeutics
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
XtalPi
XtalPi is a pharmaceutical technology company that is reinventing drug discovery by enabling dry lab predictions with wet lab validation.
Current Advisors List
Current Employees Featured
Founder
Investors List
DCVC Bio
DCVC Bio investment in Series B - Frontier Medicines
Driehaus Capital Management
Driehaus Capital Management investment in Series B - Frontier Medicines
Droia Ventures
Droia Ventures investment in Series B - Frontier Medicines
Deep Track Capital
Deep Track Capital investment in Series B - Frontier Medicines
ArrowMark Partners
ArrowMark Partners investment in Series B - Frontier Medicines
Sphera Global Healthcare Fund
Sphera Global Healthcare Fund investment in Series B - Frontier Medicines
Deerfield
Deerfield investment in Series B - Frontier Medicines
MPM Capital
MPM Capital investment in Series B - Frontier Medicines
Woodline Partners
Woodline Partners investment in Series B - Frontier Medicines
RA Capital Management
RA Capital Management investment in Series B - Frontier Medicines
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-17 | Frontier Medicines Announces the Appointment of Marguerite Hutchinson, J.D., as Chief Business Officer |
Official Site Inspections
http://www.frontiermeds.com Semrush global rank: 1.35 M Semrush visits lastest month: 21.42 K
- Host name: server-3-167-112-18.iad55.r.cloudfront.net
- IP address: 3.167.112.18
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Frontier Medicines"
Frontier Medicines - Crunchbase Company Profile
Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines. Its platform integrates advanced computational approaches and machine …See details»
Frontier Medicines: delivering breakthrough medicines
Frontier Medicines has a global strategic collaboration with AbbVie to discover, develop and commercialize a pipeline of innovative small molecule therapeutics against certain high-interest, difficult-to-drug protein targets.See details»
Frontier Medicines: delivering breakthrough medicines
South San Francisco Office 151 Oyster Point Blvd., 2nd Floor South San Francisco, CA 94080See details»
Frontier Medicines - LinkedIn
Frontier Medicines Biotechnology Research South San Francisco, CA 17,807 followers Frontier Medicines is a biopharmaceutical company that “drugs the undruggable” to transform patients’ lives.See details»
Frontier Medicines Company Profile | Management and ... - Datanyze
Www.frontiermeds.com . Contact Information. Headquarters. 151 Oyster Point Blvd, Fl 2, South San Francisco, California, 94080, United States (650) 457-1005. Frontier Medicines Profile …See details»
Frontier Medicines - PitchBook
Frontier Medicines General Information Description. Developer of a chemoproteomics platform designed to accelerate the development of medicines. The company's platform integrates …See details»
Frontier Medicines - Company Profile - Tracxn
Oct 30, 2024 Frontier Medicines - Developer of a bioinformatics platform for drug development and chemoproteomics. Raised a total funding of $236M over 3 rounds from 14 investors. …See details»
Frontier Medicines - Craft
Frontier Medicines is a biopharmaceutical company that develops medicines against disease-causing proteins. It offers chemoproteomics, machine learning, and artificial intelligence …See details»
Frontier Medicines Company Profile: AI, Investments, Contact ...
Frontier Medicines is a precision medicine company that has pioneered a powerful discovery and development platform designed to generate medicines against disease-causing proteins …See details»
Frontier Medicines - MassBio
Frontier Medicines is a precision medicine company that has pioneered a proprietary discovery and development platform to develop medicines against disease-causing proteins previously considered undruggable. We are …See details»
Frontier Medicines Announces Advancement of First Program …
Jan 10, 2022 Achievement of first milestone triggers payment to FrontierSOUTH SAN FRANCISCO, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a …See details»
Frontier Medicines - workinbiotech.com
Frontier Medicines is generating medicines to treat previously undruggable disease-causing targets. Chemoproteomics is an approach to understand the interaction between small …See details»
Frontier Medicines Announces Advancement of Second and Third …
Jan 5, 2023 SOUTH SAN FRANCISCO, Calif. and BOSTON, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to …See details»
Frontier Medicines Raises $88.5 Million Series B Financing to …
Jul 19, 2021 The proceeds will be used to advance Frontier’s wholly-owned pipeline of precision medicines against the most important drivers of cancer. The company’s lead program is …See details»
Frontier Medicines Appoints Gerardo Ubaghs as Chief Financial …
Jun 25, 2024 Our lead candidate, FMC-376, is a dual inhibitor of ON+OFF KRASG12C. FMC-376 is a potential best-in-class therapy designed to completely block both forms of the KRAS …See details»
Frontier Medicines: approach to precision medicine
Frontier is developing precision medicines against important disease-causing proteins that the biopharma industry has not been able to drug with standard pharmaceutical interventions.See details»
Working At Frontier Medicines: Company Overview and Culture
Mar 14, 2024 Find out what it's like to work at Frontier Medicines. See what kind of people work at Frontier Medicines, career paths working at Frontier Medicines, company culture, salaries, …See details»
Frontier Medicines Announces Advancement of First Program …
Jan 10, 2022 Achievement of first milestone triggers payment to Frontier SOUTH SAN FRANCISCO, Calif. -- Frontier Medicines Corporation, a precision medicine company seeking …See details»
Frontier Medicines: Explore career opportunities at Frontier …
Frontier Medicines is looking for highly qualified people who believe patients come first, science rules, & boldness is the standard operating procedureSee details»